Literature DB >> 8819581

Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995.

J A Berzofsky1, I J Berkower.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8819581

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.

Authors:  P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

2.  The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

Authors:  I M Belyakov; J D Ahlers; B Y Brandwein; P Earl; B L Kelsall; B Moss; W Strober; J A Berzofsky
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

3.  Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.

Authors:  I M Belyakov; M A Derby; J D Ahlers; B L Kelsall; P Earl; B Moss; W Strober; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens.

Authors:  Denis V Antonets; Sergei I Bazhan
Journal:  BMC Res Notes       Date:  2013-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.